Total words: 1627 | 2-word phrases: 428 | 3-word phrases: 470 | 4-word phrases: 488
Title | Try to keep the title under 60 characters (31 characters) Homepage | Alnylam Connect U.S. |
Description | Try to keep the meta description between 50 - 160 characters (219 characters) For U.S. HCPs interested in learning more about Alnylam's products or therapeutic areas, Alnylam representatives are available to speak with; fill out a contact form here and a representative will reach out to you. |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | H1 tag on the page (45 characters) Welcome to the Alnylam Contact a Rep homepage |
# | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
---|---|---|---|---|---|---|---|---|---|
1 | to | 17 | 7.05% | ||||||
2 | your | 16 | 6.64% | ||||||
3 | or | 15 | 6.22% | ||||||
4 | givlaari | 15 | 6.22% | ||||||
5 | the | 14 | 5.81% | ||||||
6 | of | 13 | 5.39% | ||||||
7 | you | 12 | 4.98% | ||||||
8 | a | 10 | 4.15% | ||||||
9 | doctor | 9 | 3.73% | ||||||
10 | are | 9 | 3.73% |
# | URL | Whois | Check |
---|---|---|---|
1 | https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw | Whois | youtube.com |
2 | https://twitter.com/alnylam | Whois | twitter.com |
3 | https://www.linkedin.com/company/alnylam-pharmaceuticals/ | Whois | linkedin.com |
4 | https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/ | Whois | alnylam.com |
5 | https://www.alnylam.com/signup-for-updates-intl/ | Whois | alnylam.com |
6 | http://news.alnylam.com/ | Whois | alnylam.com |
7 | https://www.alnylam.com/our-science/capella-rnai-innovation/ | Whois | alnylam.com |
8 | https://www.alnylam.com/contact-us/ | Whois | alnylam.com |
9 | https://www.alnylam.com/alnylam-austria/ | Whois | alnylam.com |
10 | https://www.alnylam.com/alnylam-belgium-dutch/ | Whois | alnylam.com |
11 | https://www.alnylam.com/alnylam-belgium-french/ | Whois | alnylam.com |
12 | https://www.alnylam.com/alnylam-brazil/ | Whois | alnylam.com |
13 | https://www.alnylam.ca/fr/ | Whois | alnylam.ca |
14 | https://www.alnylam.ca/ | Whois | alnylam.ca |
15 | https://www.alnylam.com/alnylam-denmark/ | Whois | alnylam.com |
16 | https://www.alnylam.com/alnylam-france/ | Whois | alnylam.com |
17 | https://www.alnylam.com/alnylam-deutschland/ | Whois | alnylam.com |
18 | https://www.alnylam.it/ | Whois | alnylam.it |
19 | https://www.alnylam.jp/ | Whois | alnylam.jp |
20 | https://www.alnylam.com/alnylam-luxembourg-french/ | Whois | alnylam.com |
21 | https://www.alnylam.com/alnylam-luxembourg-german/ | Whois | alnylam.com |
22 | https://www.alnylam.com/alnylam-netherlands/ | Whois | alnylam.com |
23 | https://www.alnylam.com/alnylam-portugal/ | Whois | alnylam.com |
24 | https://www.alnylam.com/alnylam-espana/ | Whois | alnylam.com |
25 | https://www.alnylam.com/alnylam-sverige/ | Whois | alnylam.com |
26 | https://www.alnylam.com/alnylam-switzerland-french/ | Whois | alnylam.com |
27 | https://www.alnylam.com/alnylam-switzerland-german/ | Whois | alnylam.com |
28 | https://www.alnylam.com/alnylam-switzerland-italian/ | Whois | alnylam.com |
29 | https://www.alnylam.com/alnylam-uk/ | Whois | alnylam.com |
30 | https://www.alnylam.com/about-alnylam/ | Whois | alnylam.com |
31 | https://www.alnylam.com/about-alnylam/alnylam-leadership/ | Whois | alnylam.com |
32 | https://www.alnylam.com/about-alnylam/biotechnology-innovation-organization-message/ | Whois | alnylam.com |
33 | https://www.alnylam.com/about-alnylam/diversity-inclusion/ | Whois | alnylam.com |
34 | https://www.alnylam.com/about-alnylam/patient-access-philosophy/ | Whois | alnylam.com |
35 | https://www.alnylam.com/about-alnylam/corporate-responsibility/ | Whois | alnylam.com |
36 | https://www.alnylam.com/about-alnylam/grants-and-giving/ | Whois | alnylam.com |
37 | https://www.alnylam.com/about-alnylam/grants-and-giving/independent-medical-education-programs/ | Whois | alnylam.com |
38 | https://www.alnylam.com/about-alnylam/grants-and-giving/advocacy-for-impact-grants/ | Whois | alnylam.com |
39 | https://www.alnylam.com/about-alnylam/investigator-initiated-studies/ | Whois | alnylam.com |
40 | https://www.alnylam.com/signup-for-updates/ | Whois | alnylam.com |
41 | https://www.alnylam.com/our-science/ | Whois | alnylam.com |
42 | https://www.alnylam.com/our-science/the-science-of-rnai/ | Whois | alnylam.com |
43 | https://www.alnylam.com/our-science/alnylam-scientific-advisory-board/ | Whois | alnylam.com |
44 | https://www.alnylam.com/our-science/intellectual-property/ | Whois | alnylam.com |
45 | https://www.alnylam.com/our-science/capella-rnai-innovation/ | Whois | alnylam.com |
46 | https://www.alnylam.com/our-products/ | Whois | alnylam.com |
47 | https://www.alnylam.com/alnylam-rnai-pipeline/ | Whois | alnylam.com |
48 | https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/ | Whois | alnylam.com |
49 | https://www.alnylam.com/medical-professional-resources/ | Whois | alnylam.com |
50 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/ | Whois | alnylam.com |
51 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/amyloidosis-testing-counseling/ | Whois | alnylam.com |
52 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/porphyria-testing-counseling/ | Whois | alnylam.com |
53 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/primary-hyperoxaluria-testing-counseling/ | Whois | alnylam.com |
54 | https://www.alnylam.com/medical-professional-resources/early-access-program/ | Whois | alnylam.com |
55 | https://www.alnylam.com/medical-professional-resources/early-access-program/givosiran/ | Whois | alnylam.com |
56 | https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran/ | Whois | alnylam.com |
57 | https://www.alnylam.com/medical-professional-resources/early-access-program/lumasiran/ | Whois | alnylam.com |
58 | https://www.alnylam.com/patients/ | Whois | alnylam.com |
59 | https://www.alnylam.com/patients/ | Whois | alnylam.com |
60 | https://www.alnylam.com/patients/amyloidosis/ | Whois | alnylam.com |
61 | https://www.alnylam.com/patients/porphyria/ | Whois | alnylam.com |
62 | https://www.alnylam.com/patients/primary-hyperoxaluria/ | Whois | alnylam.com |
63 | https://www.alnylam.com/patients/patient-services/ | Whois | alnylam.com |
64 | https://www.alnylam.com/patients/patient-advocacy/ | Whois | alnylam.com |
65 | https://www.alnylam.com/our-science/capella-rnai-innovation/ | Whois | alnylam.com |
66 | https://www.alnylam.com/careers/ | Whois | alnylam.com |
67 | https://www.alnylam.com/careers/ | Whois | alnylam.com |
68 | https://www.alnylam.com/careers/our-culture/ | Whois | alnylam.com |
69 | https://alnylam.taleo.net/careersection/alny_ext/jobsearch.ftl?lang=en | Whois | taleo.net |
70 | https://www.alnylam.com/about-alnylam/ | Whois | alnylam.com |
71 | https://www.alnylam.com/about-alnylam/alnylam-leadership/ | Whois | alnylam.com |
72 | https://www.alnylam.com/about-alnylam/biotechnology-innovation-organization-message/ | Whois | alnylam.com |
73 | https://www.alnylam.com/about-alnylam/diversity-inclusion/ | Whois | alnylam.com |
74 | https://www.alnylam.com/about-alnylam/patient-access-philosophy/ | Whois | alnylam.com |
75 | https://www.alnylam.com/about-alnylam/corporate-responsibility/ | Whois | alnylam.com |
76 | https://www.alnylam.com/about-alnylam/grants-at-alnylam/advocacy-for-impact-grants/ | Whois | alnylam.com |
77 | https://www.alnylam.com/signup-for-updates/ | Whois | alnylam.com |
78 | https://www.alnylam.com/our-science/ | Whois | alnylam.com |
79 | https://www.alnylam.com/our-science/the-science-of-rnai/ | Whois | alnylam.com |
80 | https://www.alnylam.com/our-science/alnylam-scientific-advisory-board/ | Whois | alnylam.com |
81 | https://www.alnylam.com/our-science/intellectual-property/ | Whois | alnylam.com |
82 | https://www.alnylam.com/our-science/capella-rnai-innovation/ | Whois | alnylam.com |
83 | https://www.alnylam.com/our-products/ | Whois | alnylam.com |
84 | https://www.alnylam.com/alnylam-rnai-pipeline/ | Whois | alnylam.com |
85 | https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/ | Whois | alnylam.com |
86 | https://www.alnylam.com/medical-professional-resources/ | Whois | alnylam.com |
87 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/ | Whois | alnylam.com |
88 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/amyloidosis-testing-counseling/ | Whois | alnylam.com |
89 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/porphyria-testing-counseling/ | Whois | alnylam.com |
90 | https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling/primary-hyperoxaluria-testing-counseling/ | Whois | alnylam.com |
91 | https://www.alnylam.com/medical-professional-resources/early-access-program/ | Whois | alnylam.com |
92 | https://www.alnylam.com/medical-professional-resources/early-access-program/givosiran/ | Whois | alnylam.com |
93 | https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran/ | Whois | alnylam.com |
94 | https://www.alnylam.com/medical-professional-resources/early-access-program/lumasiran/ | Whois | alnylam.com |
95 | https://www.alnylam.com/patients/ | Whois | alnylam.com |
96 | https://www.alnylam.com/patients/ | Whois | alnylam.com |
97 | https://www.alnylam.com/patients/amyloidosis/ | Whois | alnylam.com |
98 | https://www.alnylam.com/patients/porphyria/ | Whois | alnylam.com |
99 | https://www.alnylam.com/patients/primary-hyperoxaluria/ | Whois | alnylam.com |
100 | https://www.alnylam.com/patients/patient-services/ | Whois | alnylam.com |
101 | https://www.alnylam.com/patients/patient-advocacy/ | Whois | alnylam.com |
102 | https://www.alnylam.com/our-science/capella-rnai-innovation/ | Whois | alnylam.com |
103 | https://www.alnylam.com/careers/ | Whois | alnylam.com |
104 | https://www.alnylam.com/careers/ | Whois | alnylam.com |
105 | https://www.alnylam.com/careers/our-culture/ | Whois | alnylam.com |
106 | https://alnylam.taleo.net/careersection/alny_ext/jobsearch.ftl?lang=en | Whois | taleo.net |
107 | https://www.fda.gov/medwatch | Whois | fda.gov |
108 | https://www.alnylam.com/wp-content/uploads/pdfs/GIVLAARI-Prescribing-Information.pdf | Whois | alnylam.com |
109 | https://www.alnylam.com/privacy-policy/ | Whois | alnylam.com |
110 | https://www.alnylam.com/legal-notice/ | Whois | alnylam.com |
111 | https://alnylampolicies.com/contact#us/ | Whois | alnylampolicies.com |